/

Sociétés

65

Non vérifié

65 Equity Partners; HAS Healthcare Advanced Synthesis

Ce que nous écrivons

BanqueÉconomieGestion des obligationsIndustrie pharmaceutiqueSanté Publique

2 communiqués de presse

Voir tous les communiqués de presse

31/03/2025

Industrie pharmaceutique

Banque

Santé Publique

Finance

Hypothèques

Épargne/Affaires personnelles

Leasing

Gestion des obligations

Fonds d'investissement

Euro-obligations

Économie

HAS Healthcare Advanced Synthesis SA (HAS), Biasca, Svizzera acquisisce la società Cerbios-Pharma SA, per creare un Gruppo leader internazionale nel settore CDMO, supportato da 65 Equity Partners

Source

65 Equity Partners; HAS Healthcare Advanced Synthesis

Émetteur

1.00

0

31/03/2025

Industrie pharmaceutique

Banque

Santé Publique

Économie

HAS Healthcare Advanced Synthesis SA acquires Cerbios-Pharma SA to create leading international Group in the CDMO sector, backed by 65 Equity Partners

Source

65 Equity Partners; HAS Healthcare Advanced Synthesis

Émetteur

1.00

0

Followers

0

Compatibilité

0